Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yerong Yu

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Endocrine Journal|April 1, 2021
The usefulness of the combined high-dose dexamethasone suppression test and desmopressin stimulation test in establishing the source of ACTH secretion in ACTH-dependent Cushing's syndromeJingtao Qiao, Jiaqi Li, Weiwei Zhang, et al.
Expert Opinion on Investigational Drugs|February 11, 2025
Evaluation of pharmacokinetic and pharmacodynamic similarity of an IDegAsp biosimilar versus the originator in healthy Chinese volunteersHui Liu, Yang Xiong, Xinlei Chen, et al.
BMC Endocrine Disorders|June 19, 2019
Hypercortisolism and primary aldosteronism caused by bilateral adrenocortical adenomas: a case reportKaiyun Ren, Jia Wei, Qilin Liu, et al.
Frontiers in Endocrinology|April 5, 2024
Predictive factors and the management of hyperglycemia in patients with acromegaly and Cushing's disease receiving pasireotide treatment: <i>post hoc</i> analyses from the SOM230B2219 studyUlla Feldt-Rasmussen, Marek Bolanowski, Shao-Ling Zhang, et al.
BMC Endocrine Disorders|April 25, 2018
ACTH-independent Cushing's syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literaturesJia Wei, Sheyu Li, Qilin Liu, et al.
Pituitary|December 9, 2025
Association between vertebral fracture risk and bone mineral density in patients with acromegalyShuaiming Chen, Min Liu, Huiwen Tan, et al.
Pituitary|July 18, 2021
Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV studySusan L Samson, Feng Gu, Ulla Feldt-Rasmussen, et al.
The Journal of Clinical Endocrinology and Metabolism|January 11, 2019
Predictors of Long-Term Glycemic Remission After 2-Week Intensive Insulin Treatment in Newly Diagnosed Type 2 DiabetesHui Wang, Jian Kuang, Mingtong Xu, et al.
Frontiers in Endocrinology|August 18, 2025
Cardiac structure and function recovery in acromegaly after treatment: insights from cardiac magnetic resonance imagingYu Chen, Yangjie Li, Yu Tang, et al.
Endocrine Journal|August 25, 2024
Osilodrostat treatment in patients with Cushing's disease of Asian or non-Asian origin: a pooled analysis of two Phase III randomized trials (LINC 3 and LINC 4)Akira Shimatsu, Beverly Mk Biller, Maria Fleseriu, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Endocrine Journal|April 1, 2021
The usefulness of the combined high-dose dexamethasone suppression test and desmopressin stimulation test in establishing the source of ACTH secretion in ACTH-dependent Cushing's syndromeJingtao Qiao, Jiaqi Li, Weiwei Zhang, et al.
Expert Opinion on Investigational Drugs|February 11, 2025
Evaluation of pharmacokinetic and pharmacodynamic similarity of an IDegAsp biosimilar versus the originator in healthy Chinese volunteersHui Liu, Yang Xiong, Xinlei Chen, et al.
BMC Endocrine Disorders|June 19, 2019
Hypercortisolism and primary aldosteronism caused by bilateral adrenocortical adenomas: a case reportKaiyun Ren, Jia Wei, Qilin Liu, et al.
Frontiers in Endocrinology|April 5, 2024
Predictive factors and the management of hyperglycemia in patients with acromegaly and Cushing's disease receiving pasireotide treatment: <i>post hoc</i> analyses from the SOM230B2219 studyUlla Feldt-Rasmussen, Marek Bolanowski, Shao-Ling Zhang, et al.
BMC Endocrine Disorders|April 25, 2018
ACTH-independent Cushing's syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literaturesJia Wei, Sheyu Li, Qilin Liu, et al.
Pituitary|December 9, 2025
Association between vertebral fracture risk and bone mineral density in patients with acromegalyShuaiming Chen, Min Liu, Huiwen Tan, et al.
Pituitary|July 18, 2021
Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV studySusan L Samson, Feng Gu, Ulla Feldt-Rasmussen, et al.
The Journal of Clinical Endocrinology and Metabolism|January 11, 2019
Predictors of Long-Term Glycemic Remission After 2-Week Intensive Insulin Treatment in Newly Diagnosed Type 2 DiabetesHui Wang, Jian Kuang, Mingtong Xu, et al.
Frontiers in Endocrinology|August 18, 2025
Cardiac structure and function recovery in acromegaly after treatment: insights from cardiac magnetic resonance imagingYu Chen, Yangjie Li, Yu Tang, et al.
Endocrine Journal|August 25, 2024
Osilodrostat treatment in patients with Cushing's disease of Asian or non-Asian origin: a pooled analysis of two Phase III randomized trials (LINC 3 and LINC 4)Akira Shimatsu, Beverly Mk Biller, Maria Fleseriu, et al.
Pageof 8